Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKR) Cash & Equivalents (2016 - 2026)

Bruker filings provide 17 years of Cash & Equivalents readings, the most recent being $298.8 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 62.92% to $298.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $298.8 million, a 62.92% increase, with the full-year FY2025 number at $298.8 million, up 62.92% from a year prior.
  • Cash & Equivalents hit $298.8 million in Q4 2025 for Bruker, up from $293.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 billion in Q4 2021 to a low of $92.0 million in Q2 2025.
  • Median Cash & Equivalents over the past 5 years was $530.6 million (2021), compared with a mean of $474.5 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 70.48% in 2024 and later surged 97.91% in 2025.
  • Bruker's Cash & Equivalents stood at $1.1 billion in 2021, then tumbled by 39.57% to $645.5 million in 2022, then fell by 24.35% to $488.3 million in 2023, then plummeted by 62.44% to $183.4 million in 2024, then soared by 62.92% to $298.8 million in 2025.
  • The last three reported values for Cash & Equivalents were $298.8 million (Q4 2025), $293.1 million (Q3 2025), and $92.0 million (Q2 2025) per Business Quant data.